Deal Announcements

Cardax Pharma Lands Venture Capital Debt

Wednesday, June 19, 2013 5:34:00 AM PDT | VentureDeal

Honolulu, Hawaii  --  Cardax Pharmaceuticals has garnered $781,000 in new venture capital debt financing, according to an SEC filing.

Cardax is developing small molecule compounds that impact inflammatory pathways.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Cardax is still seeking $9.2 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1